P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Helicobacter Pylori Infection Interventions: Other: Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures...

Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Anxiety; Depression Disorders; Sleep Wake Disorders; Gastrointestinal Diseases; Preoperative Anxiety Interventions: Behavioral: Enhanced Ward-Round Frequency With Standardized Communication; Behavioral: Usual Care Ward Rounds (2/day) Sponsors: LanZhou...

Regenerative Peripheral Nerve Interfaces for the Treatment of Painful Neuromas in Major Limb Amputees

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Amputation Neuroma Interventions: Procedure: Amputation with Regenerative Peripheral Nerve Interfaces (RPNI); Other: Amputation Without RPNI Sponsors: University of Michigan Completed Conditions: Amputation Neuroma Interventions: Procedure: Amputation...

Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection Pain

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Propofol Injection Pain Interventions: Drug: propofol; Drug: Lidocaine – Propofol Mixture; Drug: Lidocaine – Bier Block Sponsors: Asma Ladib Completed Conditions: Propofol Injection Pain Interventions: Drug: propofol; Drug: Lidocaine –...

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Glioma Interventions: Device: transcranial magnetic stimulation (TMS); Device: sham stimulation Sponsors: Beijing Neurosurgical Institute Active, not recruiting Conditions: Glioma Interventions: Device: transcranial magnetic stimulation (TMS); Device:...

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Phase 2; Zanzalintinib; Pembrolizumab; Advanced/Metastatic; Soft-Tissue Sarcoma Interventions: Drug: Zanzalintinib; Drug: Pembrolizumab Sponsors: M.D. Anderson Cancer Center; Exelixis Not yet recruiting Conditions: Phase 2; Zanzalintinib; Pembrolizumab;...